267 related articles for article (PubMed ID: 28402147)
1. Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-β-cyclodextrin prepared using the liquid antisolvent precipitation and solvent removal combination methods.
Wu W; Zu Y; Zhao X; Zhang X; Wang L; Li Y; Wang L; Zhang Y; Lian B
Drug Dev Ind Pharm; 2017 Aug; 43(8):1366-1377. PubMed ID: 28402147
[TBL] [Abstract][Full Text] [Related]
2. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement.
Huang Y; Zu Y; Zhao X; Wu M; Feng Z; Deng Y; Zu C; Wang L
Int J Pharm; 2016 Sep; 511(2):921-30. PubMed ID: 27515291
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
5. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
Wang L; Li S; Cai H; Liu X; Feng T; Zhao X
J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
[TBL] [Abstract][Full Text] [Related]
8. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
9. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
10. Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity.
Wang F; Yang B; Zhao Y; Liao X; Gao C; Jiang R; Han B; Yang J; Liu M; Zhou R
J Biomater Sci Polym Ed; 2014; 25(6):594-607. PubMed ID: 24555409
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
15. [Preparation process of rutacarpine-hydroxypropyl-beta-cyclodextrin inclusion complex].
Yan CL; Zhang J; Hou Y; Xue GP; Wang S; Zhao QY
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):828-32. PubMed ID: 25204173
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
17. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
He Y; Li P; Yalkowsky SH
Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
[TBL] [Abstract][Full Text] [Related]
19. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
[TBL] [Abstract][Full Text] [Related]
20. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
